These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30564186)

  • 1. The UK ME/CFS Biobank: A Disease-Specific Biobank for Advancing Clinical Research Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lacerda EM; Mudie K; Kingdon CC; Butterworth JD; O'Boyle S; Nacul L
    Front Neurol; 2018; 9():1026. PubMed ID: 30564186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hope, disappointment and perseverance: Reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study.
    Lacerda EM; McDermott C; Kingdon CC; Butterworth J; Cliff JM; Nacul L
    Health Expect; 2019 Jun; 22(3):373-384. PubMed ID: 30632248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis.
    Lacerda EM; Bowman EW; Cliff JM; Kingdon CC; King EC; Lee JS; Clark TG; Dockrell HM; Riley EM; Curran H; Nacul L
    Open J Bioresour; 2017; 4():. PubMed ID: 28649428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis / chronic fatigue syndrome.
    Devereux-Cooke A; Leary S; McGrath SJ; Northwood E; Redshaw A; Shepherd C; Stacey P; Tripp C; Wilson J; Mar M; Boobyer D; Bromiley S; Chowdhury S; Dransfield C; Almas M; Almelid Ø; Buchanan D; Garcia D; Ireland J; Kerr SM; Lewis I; McDowall E; Migdal M; Murray P; Perry D; Ponting CP; Vitart V; Wolfe JC
    BMC Neurol; 2022 Jul; 22(1):269. PubMed ID: 35854226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study.
    Nacul L; de Barros B; Kingdon CC; Cliff JM; Clark TG; Mudie K; Dockrell HM; Lacerda EM
    Diagnostics (Basel); 2019 Apr; 9(2):. PubMed ID: 30974900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls.
    Kingdon CC; Bowman EW; Curran H; Nacul L; Lacerda EM
    Pharmacoecon Open; 2018 Dec; 2(4):381-392. PubMed ID: 29536371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci.
    Hajdarevic R; Lande A; Mehlsen J; Rydland A; Sosa DD; Strand EB; Mella O; Pociot F; Fluge Ø; Lie BA; Viken MK
    Brain Behav Immun; 2022 May; 102():362-369. PubMed ID: 35318112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
    Strassheim VJ; Sunnquist M; Jason LA; Newton JL
    BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of daily activity in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their implications for rehabilitation programmes.
    Pemberton S; Cox DL
    Disabil Rehabil; 2014; 36(21):1790-7. PubMed ID: 24369769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.
    Unger ER; Lin JS; Tian H; Natelson BH; Lange G; Vu D; Blate M; Klimas NG; Balbin EG; Bateman L; Allen A; Lapp CW; Springs W; Kogelnik AM; Phan CC; Danver J; Podell RN; Fitzpatrick T; Peterson DL; Gottschalk CG; Rajeevan MS;
    Am J Epidemiol; 2017 Apr; 185(8):617-626. PubMed ID: 28338983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A logistic regression analysis of risk factors in ME/CFS pathogenesis.
    Lacerda EM; Geraghty K; Kingdon CC; Palla L; Nacul L
    BMC Neurol; 2019 Nov; 19(1):275. PubMed ID: 31699051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study.
    Castro-Marrero J; Serrano-Pertierra E; Oliveira-Rodríguez M; Zaragozá MC; Martínez-Martínez A; Blanco-López MDC; Alegre J
    J Extracell Vesicles; 2018; 7(1):1453730. PubMed ID: 29696075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    de Vega WC; Herrera S; Vernon SD; McGowan PO
    BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.
    Rowe PC; Underhill RA; Friedman KJ; Gurwitt A; Medow MS; Schwartz MS; Speight N; Stewart JM; Vallings R; Rowe KS
    Front Pediatr; 2017; 5():121. PubMed ID: 28674681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS.
    Nacul L; O'Boyle S; Palla L; Nacul FE; Mudie K; Kingdon CC; Cliff JM; Clark TG; Dockrell HM; Lacerda EM
    Front Neurol; 2020; 11():826. PubMed ID: 32849252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.